JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.


484 *	Wed, 8/3/2011, 10:30 AM - 12:20 PM	CC-A108/109
Using Advanced Visual Analytics to Improve Safety Assessment and Decisionmaking in Drug Development — Invited Papers
Section on Health Policy Statistics , ENAR , Section on Risk Analysis , Scientific and Public Affairs Advisory Committee
Organizer(s): Brenda Crowe, Eli Lilly and Company
Chair(s): Pandurang Kulkarni, Eli Lilly and Company
10:35 AM	Safety Graphics: Graphical Approaches for Identifying Safety Signals — Janelle Charles, U.S. Food and Drug Administration/OTS/CDER
11:00 AM	Creating Effective Visual Tools for the Assessment and Characterization of Pharmaceutical Product Safety: General Principles, Illustrations, and Public Access — Kenneth J. Koury, Merck Research Laboratories
11:25 AM	Visualization Tools and the Evaluation of Safety Data in Pharmaceutical Industry Clinical Trials — Qi Jiang, Amgen Inc.
11:50 AM	Visually Displaying Benefit:Risk:Uncertainty in Safety Assessments — Mark O. Walderhaug, U.S. Food and Drug Administration ; Richard A. Forshee, U.S. Food and Drug Administration/CBER ; Arianna Simonetti, U.S. Food and Drug Administration/CBER ; Anne Fernando, Norfolk State University
12:15 PM	Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.